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Abstract
Angiosarcomas are malignant neoplasias of rapid growth that develop from endothelial cells. They
represent 2% of all sarcomas and only 1–4% are located in the aerodigestive tract. Since 1977, only
16 cases have been reported.
We present a 33-year-old male with spontaneous epistaxis that was refractory to cauterization.
During physical examination, a smooth purplish tumor of 1.5 cm × 1.5 cm was identified. A CT scan
showed a nonenhanced tumor in the left nostril on the uncinate process. A biopsy revealed an
intermediate-grade angiosarcoma. Surgical removal followed by radiation therapy was performed
with good result. Aerodigestive angiosarcomas have a better prognosis than angiosarcomas of
other locations due to better cell differentiation and the presence of early symptoms. Recurrence
can occur because of tumor tissue left during resection. Our patient continues tumor free after
three years.
Background
Angiosarcomas are malignant neoplasias of rapid growth
that originate from endothelial cells [1,2]. They represent
2% of all sarcomas, and of these, only 1–4% are localized
in the upper aerodigestive mucosa [3,4].
They appear during middle age and prognosis depends on
location, size and degree of tissue invasion.
We present a case of angiosarcoma of the nasal cavity
Case report
A 33-year-old male came to our clinic with a 5 month his-
tory of recurrent epistaxis of the left nostril described as
nasal dripping, previously treated in another center on
four occasions by cauterization of the left nasal mucosa
with persistence of bleeding. During examination of the
nose, we identified a smooth purplish tumor 1.5 cm × 1.5
cm attached to the lateral nasal wall between the inferior
and middle turbinates (Fig 1).
A CT Scan showed a nonenhancing 3 cm. tumor in the left
nasal cavity located between the inferior and middle tur-
Published: 29 January 2009
Cases Journal 2009, 2:104 doi:10.1186/1757-1626-2-104
Received: 29 September 2008
Accepted: 29 January 2009
This article is available from: http://www.casesjournal.com/content/2/1/104
© 2009 Treviño-González et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 4
(page number not for citation purposes)
Cases Journal 2009, 2:104 http://www.casesjournal.com/content/2/1/104binates at the level of the uncinate process with medial
maxillary wall erosion (Fig 2).
Resection with maxillary antrostomy, ethmoidectomy,
frontal and ipsilateral sphenoidotomy was performed.
Free margins were reported on the surgical specimen.
Thirty radiation cycles were applied until a total dose of
55 Gy was achieved.
Microscopic review of the specimen revealed a vascular
neoplasia with multiple vessels comprised of endothelial
cells with prominent nuclei and atypia (Fig 3). Elongated
fusiform nucleus cells with atypia were also observed
between the vascular areas (Fig 4). The final diagnosis was
an intermediate-grade angiosarcoma.
The patient continues symptom-free and with no evi-
dence of local or distant metastasis 3 years after initial
treatment (Fig 5).
Discussion
Upper aerodigestive angiosarcoma is a very rare tumor;
only 16 cases have been reported since 1977 (Table 1). Of
these, six were located in the paranasal sinuses and four in
the nasal cavity. Salomon [5]. from the MD Anderson
Cancer Center in Houston reported that angiosarcoma
corresponds to 1% of all sarcomas.
Nasal endoscopy that shows a tumor in the left nasal wallFigur  1
Nasal endoscopy that shows a tumor in the left nasal 
wall.
CT Scan, of paranasal sinus, that shows the tumor in the left nasal cavityFigure 2
CT Scan, of paranasal sinus, that shows the tumor in 
the left nasal cavity.
Image that corresponds to a vascular neoplasia, composed of ultiple blo d vessels urrounded by endothelial cells with atypical nucleiFigure 3
Image that corresponds to a vascular neoplasia, com-
posed of multiple blood vessels surrounded by 
endothelial cells with atypical nuclei.
On the solid areas of the tumor we observed elongated atyp-ical cells w th fusiform nuclei bet en vascular areasFigur  4
On the solid areas of the tumor we observed elon-
gated atypical cells with fusiform nuclei between vas-
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the nasal cavity after a review of the literature.
Nasal obstruction, malar edema and recurrent epistaxis
are usually present at an early phase of the disease. The
period of time for the presence of symptoms of angiosar-
comas of the head and neck is short, usually one month
[6]. This contrasts with angiosarcomas of the nasal cavity
and paranasal sinus which is usually 7.1 months [7]. Our
patient presented with a 5 month history of these symp-
toms.
Etiology is unknown and has been associated to certain
risk factors such as chronic lymphedema, radiotherapy,
vinyl chloride exposure, trauma and telangiectatic skin
lesions [8,9]
The histology of aerodigestive angiosarcomas is similar to
that of angiosarcomas at other locations. It is character-
ized by multiple vascular anastomosis, sometimes having
solid necrotic or hemorrhagic areas, particularly in high-
grade tumors. The neoplastic vessels present atypical
endothelium with prominent hyperchromatic nuclei and
can be classified in high or low grade based on their
microscopic appearance [9]
Well-differentiated tumors present vascular channels with
anastomosis, endothelial cells with large hyperchromatic
nuclei, a low mitotic index and few pseudopapillary pro-
jections into the vessel lumen contrary to poorly-differen-
tiated neoplasias, which are characterized by solid areas
with fusiform cells [10,11]
Diagnosis of angiosarcoma is established by pathological
examination of the biopsy using H&E. However, immu-
nohistochemical staining with CD34, Ulex europaeus
agglutinin I and factor VIII antigen is often required. Fac-
tor VIII-like antigen is synthesized in vascular endothelial
cells and CD34 is specifically stained in vascular endothe-
lial cells [12-14].
Radical surgery with ample margins is the treatment of
choice in patients with head and neck angiosarcoma.
There is no standard treatment for nasal cavity and para-
nasal sinus angiosarcoma. Based on a literature review,
97% of studies reported wide resection with free margins
followed by radiotherapy (4000–5000 rads) as the treat-
ment of choice. Chemotherapy has a low impact on the
disease. Kazuto Fukushima et al. reported favorable
results with the use of recombinant interleukin 2, com-
bined with surgery [9]
Free margins are the best prognostic factor for avoiding
recurrence [7,8]
Angiosarcoma of the skin or soft tissue of the head and
neck is associated with a 50% mortality rate within the
first 25 months and a 12% survival rate at 5 years, com-
pared to nasal cavity or paranasal sinus angiosarcoma,
which have a 22% survival rate at 5 years according to
grade of differentiation and early diagnosis [7]
A literature review reported a 20.8 month survival rate.
Cervical metastasis occurs in 10–15% of cases and distal
metastasis to bone, liver, lungs or skin occurs in 30% of
patients during the first 24 months of the disease.
Radical surgery followed by radiotherapy is still the treat-
ment of choice. Due to the lack of experience with these
tumors, we believe that a better approach should be
sought in order to unify criteria and provide patients with
better results.
Consent
"Written informed consent was obtained from the patient
for publication of this case report and accompanying
images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal."
3 years postoperative CT Scan showing nasal cavity with no presence of tumorFigu e 5
3 years postoperative CT Scan showing nasal cavity 
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Table 1: Reported angiosarcoma cases, 1974–2008
Author Case Age Sex Location Size Time of evolution 
before diagnosis
Symptoms Treatment
Pisani 1 67 F Hypopharynx 4 cm NR Dysphagia and 
dysphonía
Total pharyngolaryngectomy + 
RT
Solomons 2 33 M Maxillary sinus NR 6 months Epistaxis Maxillectomy + RT
Kimura 3 8 M Nasal cavity NR 12 months Epistaxis Maxillectomy + Rhinotomy
Maheshwar 4 76 M Oropharynx 7.5 × 4.5 cm 7 months Throat pain pharyngopalatectomy + RT
Mcclatchey 5 26 F Maxillary sinus NR 1 month Epistaxis RT
Williamson 6 48 M Maxillary sinus NR 6 months Pain and malar 
edema
RT + Maxillectomy
Bankaci 7 68 M Maxillary sinus NR 36 months Epistaxis, pain and 
diplopia
Maxillectomy + RT
Sharma 8 10 M Maxillary sinus NR NR molar pain and 
maxillary edema
Maxillectomy + RT
Lanigan 9 73 M Maxilla and 
maxillary sinus
5 × 3 cm 2 months Intraoral mass and 
hemorrhage
Hemimaxillectomy + RT
Zacharides 10 68 F Maxilla NR 2 months Orbital pain Chemotherapy
Zakzewska 11 58 M Maxilla NR 6 months Hemorrhagic 
lesion
Maxillectomy
Kurien 12 38 M Nasal cavity 4 × 2 cm 2 months Nasal obstruction RT + Maxillectomy
Oliver 13 69 F Oral cavity NR 3 months Facial paralysis Chemotherapy
Ferlitio 14 73 M Larynx 2 cm 8 months Dysphagia Pharyngotomy
Ordóñez 15 52 F Nasal cavity 5 × 4 cm 2 months Cephalalgia and 
epiphora
Cranial-facial Resection + RT
Fukushima 16 55 M Nasal cavity NR 4 months Epistaxis Recombinant IL-2 + Rhinotomy + 
PO RT
Treviño 17 33 M Nasal cavity 3 cm 5 months Epistaxis Ucinate process and lateral nasal 
wall resection, partial 
turbinectomy of the middle 
turbinate + RT
NR – not referred; RT – radiotherapy; PO – PostoperativePage 4 of 4
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